Therapeutic drug monitoring in the past 40 years of the JAC
Reeves, David and Lovering, Andrew and Thomson, Alison (2016) Therapeutic drug monitoring in the past 40 years of the JAC. Journal of Antimicrobial Chemotherapy, 71 (12). pp. 3330-3332. ISSN 0305-7453 (https://doi.org/10.1093/jac/dkw408)
Preview |
Text.
Filename: Reeves_Lovering_Thomson_JAC_2016_therapeutic_drug_monitoring_in_the_past_40_years_of_the_JAC.pdf
Accepted Author Manuscript Download (368kB)| Preview |
Abstract
Since the Journal was first published in 1975, papers addressing therapeutic drug monitoring (TDM) have been a regular feature. Initially they focused on laboratory aspects of drug concentration measurement then they changed more to the application of TDM in a clinical setting. Over its history, the Journal has provided its readership with the latest technological and scientific advances in TDM and has helped to drive changes in TDM that have directly impacted on patient care. These have varied from improvement in the quality of antimicrobial measurements through better identification of dosage regimens and TDM targets that help predict outcome and adverse events.
ORCID iDs
Reeves, David, Lovering, Andrew and Thomson, Alison ORCID: https://orcid.org/0000-0002-2354-6116;-
-
Item type: Article ID code: 57568 Dates: DateEvent1 December 2016Published26 August 2016AcceptedNotes: This is a pre-copyedited, author-produced PDF of an article accepted for publication in Journal of Antimicrobial Chemotherapy following peer review. The version of record Reeves, D., Lovering, A., & Thomson, A. (2016). Therapeutic drug monitoring in the past 40 years of the JAC. Journal of Antimicrobial Chemotherapy, 71(12), 3330-3332. DOI: 10.1093/jac/dkw408 Subjects: Medicine > Therapeutics. Pharmacology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 29 Aug 2016 08:53 Last modified: 11 Nov 2024 11:30 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/57568